Notice to the Media - The Chief Public Health Officer and the Deputy Chief Public Health Officer to hold a media availability on a novel coronavirus
OTTAWA, Jan. 23, 2020 /CNW/ - The Chief Public Health Officer and Deputy Chief Public Health Officer will hold a media availability to provide information on a novel coronavirus (referred to as 2019-nCoV).
While currently there are no reports of cases in Canada of this novel coronavirus, and we are not aware of any cases involving Canadians overseas, officials will be available to answer questions from the media following a brief statement.
Note that the Government of Canada is actively monitoring the outbreak of a novel coronavirus originating in Wuhan, China, and is in close contact with international partners, including the World Health Organization.
While the risk of the disease spreading to Canada is considered low, the Public Health Agency of Canada is analyzing any potential risks to Canadians on a continuous basis.
The officials will be available to answer questions from the media following their remarks.
Date January 23, 2020
Time 3:30 PM (EST)
Location Teleconference Only Toll-free (Canada/US) dial-in number: 1-877-413-4815 Passcode: 5665727#
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...
The Japan Prize Foundation (President: Hiroshi Komiyama) held an award ceremony on Tuesday, April 16 at the Imperial Hotel Tokyo in Tokyo's Chiyoda Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the...
AMSilk GmbH ("AMSilk"), a global leader in advanced materials made from spider silk-based proteins, today announces the appointments of Ralph Fraundorfer and Ctibor Kohutovic to its Management Board starting immediately.
Ralph Fraundorfer has been...
HanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models" in the Nature...
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed two contracts to provide the radiology module of its enterprise imaging solution with two university medical centers in Germany?Universitätsklinikum Tübingen...
